| Name | Title | Contact Details |
|---|
Search Discovery is a data strategy and activation company whose focus is helping you turn raw data into the right decisions. You get a smarter, more personalized approach across strategy, technology, and execution. Many companies like yours have been playing a guessing game when it comes to critical business decisions. Too often, you either dont know if you have the right data, dont know if you can trust it, or dont know exactly what to do with it. Its time to own the unknown, and only Search Discovery brings you this level of practical strategy, flexibility, and focus. Its also why so many of the worlds leading brands rely on us. And its how weve earned a client retention rate of over 90%. Search Discovery. Own the unknown.™ Search Discovery | Own the Unknown
Progress is achieved by those with the courage to reimagine whats possible. Audi was born more than a century ago with a vision of boldly challenging the status quo and is bound by a promise to imaginatively innovate. We believe the best ideas—the ideas that will define our future—will come from new ways of thinking. We believe everyone should have a voice. We believe in equality. We believe that "we" includes all of us. For these reasons, we strive to create a workplace where diverse ideas are embraced, where people can be themselves, and where everyone comes together to reinvent mobility, drive toward a more sustainable future and create amazing customer experiences.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
We understand that flood insurance can be expensive but at Superior Flood, we can help you save 20-50 percent on flood insurance coverage. Call us today.